Navigation Links
Gardasil Effective in Preventing Vaginal, Vulvar Cancers, Study Finds

Merck's human papillomavirus vaccine Gardasil is effective in preventing vaginal and vulvar tumors, according to a study to be published on Saturday in the journal Lancet, Dow Jones reports.

Gardasil in clinical trials has been shown to be 100% effective in preventing infection with strains 16 and 18, which together cause about 70% of cervical cancer cases, and about 99% effective in preventing HPV strains 6 and 11, which together with HPV strains 16 and 18 cause about 90% of genital wart cases, among women not already infected with these strains.

FDA in June 2006 approved Gardasil for sale and marketing to girls and women ages nine to 26, and CDC's Advisory Committee on Immunization Practices later that month voted unanimously to recommend that girls ages 11 and 12 receive the vaccine, which is given in a three-shot series. Merck last month announced that it has submitted an application to FDA for extended approval of Gardasil to help prevent vaginal and vulvar cancers.

After three years of follow-up, the study found that the vaccine was 71% effective in preventing vaginal and vulvar cancers related to HPV strains 16 and 18 among women who previously had been exposed to HPV strains 6, 11, 16 and 18.

It was 100% effective among women who previously had not been exposed to those strains. The vaccine was not effective in fighting vaginal or vulvar lesions that had already formed, according to the study.

According to Merck, vaginal and vulvar cancers account for about 3% and 4% of gynecological cancers, respectively. According to HealthDay News/Forbes, HPV is present in about 80% of the 6,000 vaginal and vulvar cancers diagnosed annually in the U.S.


'"/>




Page: 1

Related medicine news :

1. Gardasil vaccine for cervical cancer
2. Gardasil- Cervical Cancer Vaccine Now Approved
3. Gardasil, a cervical cancer vaccine, hits the market
4. Gardasil Hailed as one of the Biggest Research Successes
5. Cervical Cancer Vaccine Gardasil Included In Subsidized CDC program
6. Gardasil Refused Subsidy
7. School Vaccination Program to Include Cancer Drug Gardasil
8. Developing Nations to Get Gardasil at Lesser Rates from Merck Soon
9. Gardasil – Cervical Cancer Vaccine in UA
10. Acid Test - Glaxos Cervarix, and Mercks Gardasil, Compete
11. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/6/2016)... and LONDON, UK (PRWEB) , ... May 06, 2016 , ... ... for his success in changing the way the pharmaceutical industry conducts clinical trials. This ... the world’s most influential people in pharma, and he was honored as a Tech ...
(Date:5/6/2016)... New York (PRWEB) , ... May 06, 2016 , ... A wide variety of national ... Petrend Events Home, Garden and Safety Media Showcase Wednesday, May 18 from noon to 8 ... and offers a sneak peek at new and established home, garden, outdoor and safety pet ...
(Date:5/6/2016)... ... May 06, 2016 , ... Logically, spring weather, with its moderate humidity and ... too cold, dry or hot, water on the eye surface can evaporate, creating uncomfortable ... surrounding air. There’s only one problem, according to radio show and water advocate Sharon ...
(Date:5/6/2016)... ... , ... Canadian author Mark Black is a speaker, author, and life strategy coach ... world … with the help of his publisher Strategic Book Group and its subsidiary ... hospital bed waiting for a miracle: He needed a heart and double-lung transplant. From this ...
(Date:5/6/2016)... Abilene, Texas (PRWEB) , ... May 06, 2016 , ... Yisrayl Hawkins, Pastor and Overseer ... scientists and doctors, worldwide, what he has found in the Bible about helping to stop ... address it, and it is his hope that the health and science industries will pay ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... , May 5, 2016 Progra m ... trial of Oxitec , s mosquito ... Aedes aegypti by 96 %   ... a new plan to fight wild Aedes aegypti, the dangerous mosquito ... on the island of Grand Cayman .  MRCU, a global ...
(Date:5/5/2016)... 2016 Research ... the  "Europe Thrombocytopenia Market and Competitive ... their offering.       (Logo: ... latest research Europe Thrombocytopenia Market and ... comprehensive insights into Thrombocytopenia pipeline products, ...
(Date:5/4/2016)... time for an upgrade. There are many medical recorders on the market but none ... DVMAXX HD  offers unparalleled connectivity and functionality.  Ampronix  is a renowned authorized reseller ... innovative technology.  Photo - http://photos.prnewswire.com/prnh/20160503/363416 ... ... ...
Breaking Medicine Technology: